The largest database of trusted experimental protocols

Goldengate cancer panel 1 methylation bead array

Manufactured by Illumina
Sourced in United States

The GoldenGate Cancer Panel I methylation bead array is a lab equipment product from Illumina. It is designed to analyze DNA methylation patterns across a targeted panel of genes associated with cancer.

Automatically generated - may contain errors

3 protocols using goldengate cancer panel 1 methylation bead array

1

Cancer-Related DNA Methylation Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Array-based DNA methylation profiling was accomplished by using the Illumina GoldenGate Cancer Panel I methylation bead array to simultaneously interrogate 1505 CpG loci associated with 807 cancer-related genes. We previously determined that this array showed high reproducibility; results obtained in FFPE tissues were highly correlated with those from matched non-FFPE samples (r =0.97), and published tumor-specific methylation profiles were detectable when DNA specimens contained at least 70% tumor cells [21 (link)].
Bead arrays were run in the Mammalian Genotyping Core laboratory at UNC at Chapel Hill. The Illumina GoldenGate methylation assay was performed as described previously [22 (link)] and imaged by using the BeadArray Scanner. Methylation status of the interrogated CpG sites was determined by comparing the ratio of the fluorescent signal from the methylated allele with the sum from the fluorescent signals of both methylated and unmethylated alleles. Controls for methylation status used on each bead array included the Zymo Universal Methylated DNA Standard as the positive, fully-methylated control, and a GenomePlex (Sigma-Aldrich, St. Louis, MO, USA) whole genome amplified DNA used as the negative, unmethylated control. Array data have been deposited in Gene Expression Omnibus under accession number GSE51557.
+ Open protocol
+ Expand
2

DNA Methylation Profiling of Breast Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA methylation profiling was previously accomplished using the Illumina GoldenGate Cancer Panel I methylation bead array [39 (link)]. Sodium bisulfite modification of FFPE breast tumor DNA was performed using the EZ DNA Methylation Gold kit according to the manufacturer’s protocol. Bisulfite-converted tumor DNA was analyzed for methylation using the Cancer Panel I array in the Mammalian Genotyping Core facility at UNC. The Cancer Panel I array measures methylation at CpG sites in the promoter (P) or first exon (E) of cancer-related genes, including tumor suppressor genes, oncogenes, DNA repair genes, and others. Array probe names are comprised of the gene symbol followed by the position of the CpG in the P or E upstream from the transcription start site. The methylation level at each CpG site is represented by the beta (β) value, which ranged from 0 (completely unmethylated) to 1.0 (fully methylated). Probes reported to overlap a single-nucleotide polymorphism (SNP) or repeat [41 (link)] were excluded. After quality control filtering as described previously [39 (link)], methylation analysis was completed on 517 breast tumors and included 933 CpG loci in 609 genes.
+ Open protocol
+ Expand
3

DNA Methylation Profiling of Cancer Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium bisulfite conversion and subsequent purification of DNA was performed
using EZ DNA Methylation Gold kit (Zymo Research, Orange, CA, USA) according to the
manufacturer’s protocol. DNA methylation profiling was accomplished using the
Illumina Golden Gate Cancer Panel I methylation bead array (Illumina, San Diego, CA, USA)
to simultaneously interrogate 1505 CpG loci associated with 807 cancer-related genes as
previously described (Conway et al., 2011 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!